Compagnie Lombard Odier SCmA’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $103K | Hold |
1,240
| – | – | ﹤0.01% | 284 |
|
|
2025
Q1 | $101K | Sell |
1,240
-2,400
| -66% | -$195K | ﹤0.01% | 303 |
|
|
2024
Q4 | $328K | Buy |
3,640
+1,240
| +52% | +$112K | ﹤0.01% | 206 |
|
|
2024
Q3 | $237K | Sell |
2,400
-575
| -19% | -$56.8K | ﹤0.01% | 229 |
|
|
2024
Q2 | $276K | Hold |
2,975
| – | – | ﹤0.01% | 215 |
|
|
2024
Q1 | $282K | Hold |
2,975
| – | – | 0.01% | 227 |
|
|
2023
Q4 | $266K | Hold |
2,975
| – | – | ﹤0.01% | 257 |
|
|
2023
Q3 | $217K | Buy |
2,975
+2,400
| +417% | +$175K | 0.01% | 257 |
|
|
2023
Q2 | $47.8K | Buy |
+575
| New | +$47.8K | ﹤0.01% | 417 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 737 |
|
|
2022
Q3 | – | Sell |
-2,728
| Closed | -$202K | – | 722 |
|
|
2022
Q2 | $202K | Buy |
+2,728
| New | +$202K | 0.01% | 292 |
|
|
2018
Q4 | – | Sell |
-300
| Closed | -$29K | – | 595 |
|
|
2018
Q3 | $29K | Sell |
300
-1,230
| -80% | -$119K | ﹤0.01% | 458 |
|
|
2018
Q2 | $146K | Sell |
1,530
-20
| -1% | -$1.91K | 0.01% | 316 |
|
|
2018
Q1 | $136K | Sell |
1,550
-2,050
| -57% | -$180K | 0.01% | 344 |
|
|
2017
Q4 | $304K | Sell |
3,600
-11,440
| -76% | -$966K | 0.01% | 344 |
|
|
2017
Q3 | $1.3M | Sell |
15,040
-4,530
| -23% | -$392K | 0.05% | 197 |
|
|
2017
Q2 | $1.51M | Buy |
19,570
+300
| +2% | +$23.1K | 0.05% | 194 |
|
|
2017
Q1 | $1.34M | Sell |
19,270
-6,300
| -25% | -$437K | 0.05% | 203 |
|
|
2016
Q4 | $1.51M | Buy |
25,570
+1,000
| +4% | +$59.2K | 0.04% | 214 |
|
|
2016
Q3 | $1.63M | Buy |
24,570
+14,770
| +151% | +$979K | 0.05% | 209 |
|
|
2016
Q2 | $530K | Buy |
9,800
+9,500
| +3,167% | +$514K | 0.02% | 332 |
|
|
2016
Q1 | $15K | Hold |
300
| – | – | ﹤0.01% | 847 |
|
|
2015
Q4 | $21K | Hold |
300
| – | – | ﹤0.01% | 794 |
|
|
2015
Q3 | $19K | Hold |
300
| – | – | ﹤0.01% | 706 |
|
|
2015
Q2 | $25K | Hold |
300
| – | – | ﹤0.01% | 695 |
|
|
2015
Q1 | $23K | Buy |
+300
| New | +$23K | ﹤0.01% | 851 |
|